Learn More
BACKGROUND Occasionally, patients with hepatocellular carcinoma (HCC) who receive radioembolization with palliative intent are downstaged for radical treatments. The aim of this study was to describe(More)
2529 Background: PET offers a non invasive tool to assess cancer biology, staging tumors and potentially monitoring treatment response, anti-angiogenic therapy included. The aim of this study was to(More)
TPS153 Background: Despite several investigations, currently there are no proven biomarkers of bevacizumab efficacy. These studies are in advanced cancers and types of biomarkers and/or time points(More)